Navigation Links
CRN responds to JAMA fish oil study
Date:10/19/2010

WASHINGTON, D.C., October 19, 2010In response to a study regarding fish oil use during pregnancy published in the October 19 issue of the Journal of the American Medical Association (JAMA), the Council for Responsible Nutrition (CRN), the leading trade association for the dietary supplement industry, reminds pregnant and lactating women of the undisputed importance of consuming the recommended amounts of docosahexaenoic acid (DHA) throughout pregnancy. This can be done by eating two servings of fatty fish, such as sardines or anchovies, per week, or taking fish oil supplements (containing 200-300 mg/DHA, according to the Institute of Medicine) daily. While the benefits of DHA for a healthy pregnancy are well-established, more research is necessary to determine the effect of DHA on incidence of post-partum depression or neurocognitive development of infants.

"A large body of scientific evidence has established a strong relationship between the DHA status of mothers and infants and a variety of important pregnancy-related outcomes, including infant development," said Duffy MacKay, N.D., vice president, scientific & regulatory affairs, CRN. "Unfortunately in this trial, we have no idea of the DHA status of the mothers at the beginning of pregnancy or when they were evaluated for depression. Further we have no idea of the DHA status of the infants at 18 months when they were evaluated for neurocognitive outcomes. Without measurements of DHA status, it is difficult to draw conclusions from the study and certainly should not provide definitive advice to consumers."

There are many established variables that would impact individual DHA status for the mothers and children of both the supplemented and control group in this study, including differences in the ability to synthesize DHA from other fatty acids, the rate of maternal to fetal transfer of DHA, the status of other nutrients required to synthesize DHA, as well as other dietary sources of DHA not controlled for.

Dr. MacKay continued that the timeliness of the dosing may have had an impact. "Supplementation occurred from mid-term to deliverywe know that maternal DHA status returns to below pre-pregnancy levels within a few weeks from delivery. A mother in the treatment group who started the trial with low DHA status would have returned to pre-pregnancy status by the time she was evaluated for depression at six weeks and six months post delivery. We may have seen different results if these women took fish oil consistently leading up to, during and after pregnancy, or if we were able to stratify the results based on DHA status."

This applies to the findings for the infants, as well, as there is no information about what they were given in the eighteen month period following birthsome infants in the control group may have received DHA through breast milk if the mother was eating fish or taking fish oil supplements, or through DHA-enriched formula.

"Essentially, DHA status needs to be adequate throughout pregnancy for women and their infants to receive the many established benefits," continued Dr. MacKay. "We must also remember that both depression and childhood development are impacted by many different variables and maintaining good nutrition is just one important preventive step mothers can take to achieve the best outcomes. Taking fish oil has so many benefits; although this study did not prove that DHA dramatically impacted these complicated issues under these specific conditions, it's still widely known to be important for pregnant women and their offspring."

The DHA to Optimize Mother Infant Outcome (DOMInO) trial was conducted in five Australian maternity hospitals of 2,399 pregnant women who were less than 21 weeks' gestation to determine if taking fish oil provided 1) reduced risk of depressive symptoms in the postnatal period, and 2) improved developmental outcomes in the offspring.

Secondary study findings showed that the women supplemented with DHA had lower incidence of preterm birth and lower incidence of low birth weight offspring, which is associated with a variety of positive long-term outcomes, including better cognitive development. Aside from its heart benefits, fish oil is also important for mothers-to-be as it is known to reduce inflammation and promote brain, skin, bone and eye health.

"As the accompanying editorial acknowledges, taking fish oil can contribute to an overall healthy pregnancy. We encourage pregnant and lactating women, and all women of childbearing age to talk with their doctors and make sure they are receiving adequate amounts of DHA," said Dr. MacKay. "Additionally, these women should take 400 mcg of folic acid to help prevent neural tube birth defects. There are many things women can do to help optimize their health and wellness during pregnancyand at the end of the day all of this translates into better health for their baby."


'/>"/>

Contact: Erin Hlasney
ehlasney@crnusa.org
202-204-7684
Council for Responsible Nutrition
Source:Eurekalert

Related biology news :

1. New and unexpected mechanism identified how the brain responds to stress
2. Gene predicts how brain responds to fatigue, human study shows
3. Autism Speaks responds to recent publications citing autism clusters in California
4. New subtype of breast cancer responds to targeted drug
5. AMP responds to Genetic Test Registry request for information
6. Long-term study shows effect of climate change on animal diversity
7. £2 million study to reveal workings of dementia genes
8. New study looks to define evangelicals and how they affect polling
9. CU-Boulder study suggests air quality regulations miss key pollutants
10. Researchers study acoustic communication in deep-sea fish
11. Study reveals homeowner perceptions in fire-prone areas
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/2/2016)... -- Perimeter Surveillance & Detection Systems, Biometrics ... Support & Other Service  The latest report ... analysis of the global Border Security market . ... $17.98 billion in 2016. Now: In November ... software and hardware technologies for advanced video surveillance. ...
(Date:5/12/2016)... WearablesResearch.com , a brand of Troubadour Research & ... Q1 wave of its quarterly wearables survey. A particular ... a program where they would receive discounts for sharing ... "We were surprised to see that so many ... CEO of Troubadour Research, "primarily because there are segments ...
(Date:4/26/2016)... and LONDON , ... Finacle, part of EdgeVerve Systems, a product subsidiary ... Onegini today announced a partnership to integrate the ...      (Logo: http://photos.prnewswire.com/prnh/20151104/283829LOGO ) ... provide their customers enhanced security to access and ...
Breaking Biology News(10 mins):
(Date:6/27/2016)... 27, 2016  Liquid Biotech USA ... of a Sponsored Research Agreement with The University ... (CTCs) from cancer patients.  The funding will be ... correlate with clinical outcomes in cancer patients undergoing ... then be employed to support the design of ...
(Date:6/24/2016)... 24, 2016  Regular discussions on a range of subjects ... the two entities said Poloz. Speaking at a ... , he pointed to the country,s inflation target, which ... "In certain areas ... have common economic goals, why not sit down and address ...
(Date:6/24/2016)... ... 2016 , ... While the majority of commercial spectrophotometers and fluorometers use the ... models are higher end machines that use the more unconventional z-dimension of 20mm. ... the bottom of the cuvette holder. , FireflySci has developed several Agilent flow ...
(Date:6/23/2016)... ... June 23, 2016 , ... ... of its second eBook, “Clinical Trials Patient Recruitment and Retention Tips.” Partnering with ... in this eBook by providing practical tips, tools, and strategies for clinical researchers. ...
Breaking Biology Technology: